SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced...
Emerald is a bioagriculture company developing and manufacturing naturally occurring biochemicals for the enhancement of yield, quality and disease control in crops. We invested largely on the promise of its lead product, a growth-enhancing reagent containing GABA (gamma amino butyric acid), a non-protein amino acid that helps regulate mineral availability in plants. Use of the product can enhance flowering, increase fruit size, improve yields and suppress disease. Our stock in Emerald was repurchased by the company in 2009.
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.